Current perspectives on the immunopathogenesis of systemic sclerosis

Area of Science:

• Immunology
• Rheumatology
• Autoimmune Diseases

Background:

• Systemic sclerosis (SSc), also known as scleroderma, is a progressive autoimmune disorder.
• It is characterized by inflammation, vasculopathy, and fibrosis, leading to high fatality rates.
• Current therapies cannot reverse or slow SSc progression due to its complex pathogenesis.

Purpose of the Study:

• To review recent advancements in understanding SSc pathogenesis.
• To focus on the immunopathogenetic mechanisms initiating and driving SSc.
• To provide insights for developing novel therapeutic strategies.

Main Methods:

• Literature review of recent research on SSc pathogenesis.
• Analysis of studies focusing on immune system activation in SSc.
• Synthesis of findings on autoimmune initiation and effector pathways.

Main Results:

• SSc is a heterogeneous disease with significant impact on skin and internal organs.
• Immune system activation is central to SSc, but initiation mechanisms are unclear.
• Understanding immunopathogenesis is crucial for effective SSc treatment.

Conclusions:

• Despite improved outcomes, no cure for SSc exists.
• Further research into SSc immunopathogenesis is essential.
• Targeting immune pathways may offer future therapeutic avenues for SSc.